Dr. Naval Mendiratta is the director of Rheumatology Department at the Fortis Hospital, Gurgaon.
He has over 12 years of experience in the field, with prestigious positions such as Consultant in the past.
Dr. Mendiratta is an accomplished rheumatologist who completed his MBBS from Chennai in 2006.
He also completed his MD in General Medicine from Pune and he specializes in Clinical Fellowship in Rheumatology and Immunology from Singapore.
He has an extensive experience at different hospitals, starting his journey as a Senior Resident to now holding the Senior Consultant Rheumatologist role.
He manages OPD, specialized procedures and advanced treatments.
He actively participates in academia and research, with numerous cases at national and international conferences.
He has been a chairperson and guest faculty at various medical conferences, delivering lectures on Vasculitis and other autoimmune disorders.
Dr. Mendiratta has contributed to medical literature including several in reputed journals and online abstracts.
He has also been a co-investigator in drug trials for JAK inhibitors, ANCA-associated vasculitis.
Dr. Naval also holds a membership at the Medanta Safety Monitoring Committee.
He has co-authored a book on myocardial infarction and currently supervises DNB Rheumatology theses.
Ranked No. 2 in Delhi NCR’s Best Private Hospitals by The Week Magazine Survey, 2019 India's 1st robot-assisted Joint Replacement Surgery JCI & NABH Accredited Hospital.
Founded in 2013, Fortis Memorial Research Institute (FMRI) Hospital Gurgaon is a multi-super specialty hospital equipped with world-class infrastructure and highly qualified medical professionals, including super sub-specialists
Achieved rank 2 in a global study of ‘30 Most Technologically Advanced Hospitals in the World'
Top specialties of the hospital include cardiac sciences, gastroenterology and hepatobiliary sciences, hematology, nephrology, neurology, oncology
A flagship hospital of the extended Fortis network of hospitals, FMRI has set new benchmarks as a leading adopter of new technology and excellence in clinical care
At a national level, FMRI operates the second-largest program for bone marrow transplants, performing over 200 transplants in the last year
International patients comprise approximately 22 percent of the total patient volume, and can avail of dedicated features such as translators, prayer rooms, money exchange, and international patient lounges
Fortis Memorial Research Institute is accredited by the Joint Commission International (JCI), the National Accreditation Board for Hospitals & Healthcare Providers (NABH), and the National Accreditation Board for Testing and Calibration Laboratories (NABL)